In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

  • To me, Cancer Commons has not only been a great resource but I feel the people I’ve dealt with are my friends. They give me a great sense of comfort. My questions and concerns are always addressed very promptly. I would highly recommend Cancer Commons.

    Susan
    Wife of glioblastoma patient

  • Cancer Commons is such a unique concept of providing free guidance in the times that you need it the most. Having access to their expertise and knowledge is invaluable. Could not be more thankful for Cancer Commons!

    Justyna Poweska
    Wife of a brain cancer patient

  • I appreciated the quick response after my registration with Cancer Commons. The nurse navigator was prompt and compassionate. I knew my request wasn’t going to be buried and didn’t have time to wonder how long it would take before I got a response. The scientist Lauren connected me too was very prompt in giving me answers to my question. And when I asked questions... Read more »

    Gail Lung cancer patient
  • Now is the time to be very actively involved in your own care.

    Tony Blau, MD
    University of Washington

  • This free-of-charge, high-quality information service is a wonderful resource for patients with advanced cancer.

    Hope S. Rugo, MD
    UCSF Comprehensive Cancer Center

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.